Comments from the Editor-in-Chief.
R J
RJ
Arceci
D019797:3-Iodobenzylguanidine; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D006566:Herpesviridae Infections / Q000150:complications; D004854:Herpesvirus 4, Human; D006646:Histiocytosis, Langerhans-Cell; D006801:Humans; D009447:Neuroblastoma / Q000000981:diagnostic imaging* / Q000556:secondary; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000821:virology; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D014412:Tumor Virus Infections / Q000150:complications
D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine; D001215:Asparaginase